CEO of Pfizer Vaccine Moves to Competitor to GlaxoSmithKline

Pfizer Inc’s chief viral vaccinology executive is leaving drug giant to rival GlaxoSmithKline PLC, a high-profile industry move that comes as Pfizer and other vaccine makers scramble to assess how their shots will counter a new variant of the vaccine. Corona virus that causes Covid-19.

GSK said Philippe Dormitzer, Pfizer’s former chief scientific officer for viral vaccines, will join the British pharmaceutical giant as global head of vaccine research and development. The company said its first day will be Friday.

.

Leave a Reply

Your email address will not be published.